Timbie Thomas E's Form 4 filing
Treace Medical Concepts, Inc. (TMCI) · filed Feb 17, 2023
- Accession no.
- 0001209191-23-010852
- Filed
- Feb 17, 2023
- Trade date
- Feb 15-16, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.09M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Timbie Thomas ECIK 0001188309 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 15, 2023 | Common Stock | SSaleDisposed | −50,000 | $21.71 | −$1,085,500 | 1,199,069 | Indirect | |
| Feb 16, 2023 | Common Stock | GGiftDisposed | −8,300 | $0.00 | $0 | 361,700 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.